SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-017227
Filing Date
2017-08-10
Accepted
2017-08-10 15:54:45
Documents
3
Period of Report
2017-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20170810.htm 8-K 29734
2 EX-99.1 apvo-ex991_6.htm EX-99.1 274153
3 GRAPHIC g201708101829130344845.jpg GRAPHIC 2623
  Complete submission text file 0001564590-17-017227.txt   308791
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 171021396
SIC: 2834 Pharmaceutical Preparations